Black Diamond Therapeutics, Inc. (BDTX)
1.78
-0.08
(-4.30%)
USD |
NASDAQ |
Oct 30, 16:00
1.77
-0.01
(-0.56%)
After-Hours: 20:00
Black Diamond Therapeutics EPS Diluted (Quarterly) : -0.1727 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1727 |
| March 31, 2026 | -0.1579 |
| December 31, 2025 | -0.2648 |
| September 30, 2025 | -0.1493 |
| June 30, 2025 | -0.1859 |
| March 31, 2025 | 0.9804 |
| December 31, 2024 | -0.2824 |
| September 30, 2024 | -0.2753 |
| June 30, 2024 | -0.361 |
| March 31, 2024 | -0.3518 |
| December 31, 2023 | -0.3758 |
| September 30, 2023 | -0.4516 |
| June 30, 2023 | -0.5245 |
| March 31, 2023 | -0.5722 |
| December 31, 2022 | -0.5792 |
| September 30, 2022 | -0.5958 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.6318 |
| March 31, 2022 | -0.7032 |
| December 31, 2021 | -0.714 |
| September 30, 2021 | -0.9685 |
| June 30, 2021 | -0.9494 |
| March 31, 2021 | -0.8388 |
| December 31, 2020 | -0.6281 |
| September 30, 2020 | -0.4986 |
| June 30, 2020 | -0.4058 |
| March 31, 2020 | -0.3382 |
| December 31, 2019 | -0.275 |
| September 30, 2019 | -0.258 |
| June 30, 2019 | -5.988 |
| March 31, 2019 | -0.1066 |
| December 31, 2018 | -0.0854 |
| September 30, 2018 | -0.0657 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | -0.0304 |
| Armata Pharmaceuticals, Inc. | -0.272 |
| Voyager Therapeutics, Inc. | -0.4042 |
| Invivyd, Inc. | -0.1385 |
| Elicio Therapeutics, Inc. | -0.427 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.905M |
| Total Expenses (Quarterly) | 9.905M |
| Enterprise Value | 8.718M |
| Earnings Yield | -41.84% |
| Normalized Earnings Yield | -36.77 |